Cholesterol reducer and thrombolytic therapy in acute ischemic stroke patients

BACKGROUND: Specific clinical risk factors may contribute to improving or worsening neurological functions in acute ischemic stroke (AIS) patients pre-treated with a combined cholesterol reducer and recombinant tissue plasminogen activator (rtPA) therapy. In this study, clinical risk factors associa...

Descripción completa

Detalles Bibliográficos
Autores principales: Poupore, Nicolas, Strat, Dan, Mackey, Tristan, Brown, Katherine, Snell, Ashley, Nathaniel, Thomas I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201805/
https://www.ncbi.nlm.nih.gov/pubmed/32375780
http://dx.doi.org/10.1186/s12944-020-01270-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201805/
https://www.ncbi.nlm.nih.gov/pubmed/32375780
http://dx.doi.org/10.1186/s12944-020-01270-2

Ejemplares similares